The third edition of the Ray Kennedy Cup is about to kick off in Denmark – are you up for the challenge?
The organisers of the Ray Kennedy Cup – an international football tournament for people living with Parkinson’s – are inviting players from across Europe to enter the competition.
The event, run by the Danish Parkinson’s Association (Parkinsonforeningen), takes place in Copenhagen on 19 September 2015.
This year, the organisers expect teams from Denmark, Norway, and Sweden –and, they hope, other European countries – will travel to Copenhagen to take part in the 7-a-side tournament.
The Ray Kennedy Cup – the closest thing the international Parkinson’s community has to a football world cup – is the brainchild of physiotherapist Finn Egeberg Nielsen, who realised from his work with Parkinson’s patients that the movements required in football were very similar to the ones that he asked his patients to perform.
The tournament is named after English professional footballer Ray Kennedy who was diagnosed with young-onset Parkinson’s at the end of his playing career.
It is widely acknowledged that keeping active is extremely helpful in combating the progression of Parkinson’s. The organisers believe the Ray Kennedy cup has benefits beyond this by creating a sociable, fun environment for people with Parkinson’s to interact with one another.
Heino Jespersen, member of the board of the Danish Parkinson’s Association said: “I’m sure that football and exercise can alleviate the burden of the disease. This tournament shows that a Parkinson’s diagnosis is not the end of that physical activity, it is not the end of life.”
For more information, or to find out how you and your team can get involved, contact: firstname.lastname@example.org
Raymond Kennedy (born 28 July 1951) is a former English footballer, who has played for Arsenal and Liverpool in the 1970s. The third May 1971 Ray won The League with Arsenal, who thus were Champions for the first time since 1952-53. A few days later the team won the FA Cup. Ray was top scorer in 1971-72 and again in 1973-74, and moved to Liverpool in 1974. He has also played 17 games for England. He retired in 1984 at the age of 32 years due to Parkinson’s disease.
Olie Westheimer: the visionary behind Dance for PD
Award-winner speaks about her work in Parkinson’s community
2 days ago
Chemical used in dry cleaning may be associated with Parkinson’s disease
The chemical trichloroethylene (TCE) has been used across a number of industries: to decaffeinate coffee, degrease metal parts, remove stains and dry-clean clothing. It’s currently banned in the European Union and the US states New York and Minnesota, except for authorised industrial uses. Now, scientists led by Dr Ray Dorsey in the US have conducted new research claiming that TCE could be linked to an increased risk of Parkinson’s. Published in the ‘Journal of Parkinson’s Disease’, the study investigated case studies of seven people who were exposed to TCE prior to a Parkinson’s diagnosis – including basketball legend Brian Grant. The researchers “postulate that this ubiquitous chemical is contributing to the global rise of Parkinson’s and that TCE is one of its invisible and highly preventable causes”. They called for the cleaning of TCE-contaminated sites and for indoor air exposure to be diminished – as well as for further studies to be…
Could certain cancers be linked to Parkinson’s disease?
Previous research has suggested that people with Parkinson’s may generally be less likely to develop most cancers. However, a new international study has found a potential genetic link between certain types of cancer and the condition. The team analysed genetic data from genome-wide association studies – a research approach that aims to identify gene variations associated with disease risk – to recognise common genetic risk factors between cancer and Parkinson’s. The findings uncovered a genetic link between the condition and both prostate cancer and melanoma. Meanwhile, the sum of various gene variants (otherwise known as the polygenic risk score) that contribute to Parkinson’s was significantly associated with a higher risk of breast cancer. “Our results suggest the importance of shared genetic variants between Parkinson’s and some cancers,” the researchers concluded in the study, which was published in the medical journal ‘Movement Disorders’. They highlighted the need for further studies to…
Investigational Parkinson’s disease dementia therapy fails in clinical trial
Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…